marginally significantp = 0·045
Another important finding was that in the competing risk analysis of the secondary outcome, the early treatment group, compared with the watch-and-wait group, showed a significantly decreased risk of RT complication-related death, whereas there was a marginally significant difference in cancer-related death ( p = 0·045).